Status:

UNKNOWN

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Lead Sponsor:

The University of Texas Medical Branch, Galveston

Conditions:

Pre-Eclampsia

Gestational Hypertension

Eligibility:

FEMALE

18-50 years

Phase:

PHASE3

Brief Summary

Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.

Detailed Description

To evaluate effectiveness of hydrochlorothiazide prophylaxis on prophylaxis, prevention and relapse of preeclampsia or gestational hypertension on readmission rates, need for additional antihypertensi...

Eligibility Criteria

Inclusion

  • Maternal age ≥ 18 years and \<50 years.
  • Diagnosis of gestational hypertension\* or preeclampsia\^ at any time during pregnancy, labor or postpartum.
  • defined as isolated systolic BP of 140 mm Hg or greater, a diastolic BP of 90 mm Hg or greater, or both) or \^ defines as new-onset hypertension plus new-onset proteinuria, or in the absence of proteinuria, preeclampsia is diagnosed as hypertension in association with thrombocytopenia (platelet count less than 100,000/microliter), impaired liver function (elevated blood levels of liver transaminases to twice the normal concentration), the new development of renal insufficiency (elevated serum creatinine greater than 1.1 mg/dL or a doubling of serum creatinine in the absence of other renal disease), pulmonary edema, or new-onset cerebral or visual disturbances.)

Exclusion

  • Subject requiring antihypertensive therapy at time of screening.
  • Planned discharge with oral anti-hypertensive medication.
  • Contraindication to hydrochlorothiazide (advanced renal failure or anuria, hypersensitivity to sulfonamides).
  • Subject not able to follow up postpartum.
  • Lactose intolerance.
  • Pre-gestational diabetes.

Key Trial Info

Start Date :

November 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2024

Estimated Enrollment :

612 Patients enrolled

Trial Details

Trial ID

NCT03298802

Start Date

November 21 2017

End Date

August 30 2024

Last Update

December 5 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

St. David's North Austin Medical Center

Austin, Texas, United States, 78758

2

University of Texas Medical Branch

Galveston, Texas, United States, 77555